Coalesce Research Group is pleased to announce the 3rd International Conference on Rare Diseases and Orphan Drugs, set to take place on October 27–28, 2025, in Singapore City, Singapore. This two-day conference is designed to serve as a global platform for experts, stakeholders, and advocates to discuss advancements, challenges, and opportunities in the rare diseases and orphan drugs sector.
Theme : Advancing Frontiers: Breakthroughs in Rare Diseases and Orphan Drugs
The conference will explore key topics such as neuroplasticity, the impact of trauma on brain function, depression, anxiety, and emerging insights into the mind-brain axis.
We are pleased to welcome you to the 4th International Conference on Neuroscience and Mental Health, themed "Neuroscience and Mental Health: Healing Mind, Brain, and Society," which will take place on May 14–15, 2026, in Kuala Lumpur, Malaysia.
The conference agenda covers a comprehensive range of topics, including but not limited to cardiovascular diseases and disorders, advanced imaging techniques such as echocardiography and cardiac MRI, and innovative treatments for heart failure and myocardial infarction.
In a very short duration, Magnus group succeeded in mounting a unique platform for professionals, budding researchers and experts from different countries, universities, hospitals, research institutions, industries and companies, building an opportunity to easily socialize and discuss their goals, techniques of research, latest science discoveries, facts and news.
The COPD 2025 serves as a dynamic platform to explore the latest advancements in diagnosing, managing, and treating chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and other respiratory disorders.
We invite ophthalmologists, ophthalmology specialists, optometry specialists, eye surgeons, students, and more to join the 5th International Conference on Vision Science & Optometry held on April 24-25, 2026, in Tokyo, Japan.